Analyst
UTI
Equibles does not estimate personal net worth.
Ashish T is recorded as Analyst at UTI. Ashish T has spoken on 3 earnings calls across 3 companies, most recently for Yatharth Hospital & Trauma Care Services Limited on August 11, 2026. Those appearances were for Yatharth Hospital & Trauma Care Services Limited, Anthem Biosciences Limited and Cohance Lifesciences Limited. The companies whose calls Ashish T spoke on are classified in the Healthcare sector.
“So excluding this model town in Faridabad, EBITDA margins are pretty high at 28%, but obviously including the losses, they are lower. When do you expect the new assets to fall in line and possibly when shall we start clocking 26-27% EBITDA margin again?”
“If you could also talk about specialty ingredient, what is the kind of order book that we are dealing with right now? Because is this segment currently a victim of de-stocking, as we can see in the revenue growth numbers?”
“So given that, you know, between the standard and the console, there's a difference in the margins. So I wanted to have some details on Sephora and NGA Bio. What is the projected timeline for consolidated margins to return to the historical benchmark of 30%?”
UTI
Analyst
Transcript header (unverified)
Yatharth Hospital & Trauma Care Services Limited
Medical Care Facilities · Healthcare
Anthem Biosciences Limited
Biotechnology · Healthcare
Cohance Lifesciences Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended June 30, 2026
Yatharth Hospital & Trauma Care Services Limited
Anthem Biosciences Limited Q4 & FY26 Earnings Conference Call
Anthem Biosciences Limited
Earnings Call for the Quarter Ended March 31, 2026
Cohance Lifesciences Limited
